Article
Biological characterization and chemokine receptor usage of HIV type 1 isolates prevalent in Brazil.
Registro en:
FERRARO, G. A. et al. Biological characterization and chemokine receptor usage of HIV type 1 isolates prevalent in Brazil. AIDS Research and Human Retroviruses, v. 17, n. 13, p. 1241-1247, 2001.
0889-2229
Autor
Ferraro, Geraldo Argolo
Mello, Marco Antônio Gomes
Sutmöller, Frits
Van Weyenbergh, Johan Jozef Rosa Maria
Brazilian Network For HIV isolation and characterizationI
Shindo, Nice
Castro Filho, Bernardo Galvão
Bou-Habib, Dumith Chequer
Resumen
The human immunodeficiency virus type 1 (HIV-1), the etiological agent of the acquired immunodeficiency
syndrome (AIDS), shows a variety of biological properties, which may constitute an obstacle to development
of effective vaccines or antiretroviral therapy. To characterize Brazilian strains of HIV-1, we studied 24 viruses
isolated from blood samples of HIV-1-positive patients from different regions of the country. To examine the
cell tropism and the virus ability to form syncytia, primary macrophages and the CD41 T cell line MT-2 were
infected with these viruses. We found that 22 isolates replicated well in macrophages (macrophage-tropic isolates),
2 infected only MT-2 cells (T cell line tropic variants), while 6 of them grew in both cells. We found 8
syncytium-inducing (SI) and 16 non-SI (NSI) isolates. Continuous cultures of 18 isolates were established in
the CCR51 /CXCR41 cell line PM-1, and SI/NSI features of these viruses were confirmed by cell fusion assay
with uninfected CD41 T cell lines (PM-1, MT-2, H9, and SUP-T1). The coreceptor usage of 18 isolates was
investigated by infecting U87 cells transfected with CD4 and chemokine receptors, and we found that 11 isolates
infected only CCR51 cells, 3 only CXCR41 cells, whereas 4 used both coreceptors. We also observed
that X4 isolates were more sensitive to neutralization by dextran sulfate than R5 or R5X4 viruses. Our findings
show that the Brazilian isolates are phenotypically similar to those prevalent in other regions, which could
mean that therapeutic strategies based on HIV-1 phenotypic properties would be efficient in Brazil, as in other
countries.